Initiator Pharma A/S
SSE:INIT.ST
8.08 (SEK) • At close February 20, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) SEK.
| 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2018 Q4 | 2018 Q3 | 2018 Q2 | 2018 Q1 | 2017 Q4 | 2017 Q3 | 2017 Q2 | 2017 Q1 | 2016 Q4 | 2016 Q3 | 2016 Q2 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.001 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 3.657 | 2.901 | 0.003 | 4.504 | 0.008 | 8.033 | 0.006 | 5.523 | 0.013 | 14.569 | 6.777 | 8.856 | 4.409 | 1.584 | 1.953 | 2.553 | 2.578 | 2.215 | 2.413 | 1.755 | 2.943 | 1.255 | 2.208 | 3.428 | 2.953 | 2.85 | 3.482 | 2.132 | 1.684 | 0.882 | 0.885 | 0.164 | 0.002 |
| Gross Profit
| -3.657 | -2.901 | -0.003 | -4.504 | -0.008 | -8.033 | -0.006 | -5.523 | -0.013 | -14.569 | -6.777 | -8.856 | -4.409 | -1.584 | -1.953 | -2.553 | -2.578 | -2.215 | -2.413 | -1.755 | -2.943 | -1.255 | -2.207 | -3.428 | -2.953 | -2.85 | -3.482 | -2.132 | -1.684 | -0.882 | -0.885 | -0.164 | -0.002 |
| Gross Profit Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -2,207 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 0 | 0 | 0.001 | 0.003 | 0.006 | 0.006 | 0.003 | 0.003 | 0.006 | 12.578 | 3.755 | 4.698 | 3.185 | 0.169 | 0.578 | 1.731 | 1.381 | 0 | 2.212 | 0.827 | 2.336 | 0 | 1.156 | 2.514 | 2.173 | 0 | 3.245 | 1.477 | 1.128 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 0 | 0 | 0 | 0 | -0.699 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.532 | 0 | 0 |
| SG&A
| 0 | 0.676 | 0.002 | 0.001 | -0.699 | 0.001 | 0.001 | 0.001 | 0.001 | 0.506 | 0.503 | 0.2 | 0.53 | 0.168 | 0.11 | 0.495 | 0.433 | 0.168 | 0.069 | 0.192 | 0.439 | 0.186 | 0.278 | 0.249 | 0.319 | 0.239 | 0.359 | 0.31 | 0.317 | 0.311 | 0.532 | 0 | 0.003 |
| Other Expenses
| 0 | 0 | 0 | 0 | 0 | 0.644 | 0.968 | 1.166 | 0.675 | 0.506 | 0.503 | 0.2 | 0.535 | 0.208 | 0.116 | 0.504 | 0.435 | 0.177 | 0.09 | 0.214 | 0.461 | 0.208 | 0.301 | 0.271 | 0.341 | 0.261 | 0.381 | 0.332 | 0.339 | 0.329 | 0.181 | -0.164 | 0.003 |
| Operating Expenses
| 1.334 | 0.676 | 0.002 | 0.687 | 0.699 | 0.644 | 0.968 | 1.166 | 0.675 | 0.506 | 0.503 | 0.2 | 0.535 | 0.208 | 0.116 | 0.504 | 0.435 | 0.177 | 0.09 | 0.214 | 0.461 | 0.208 | 0.301 | 0.271 | 0.341 | 0.261 | 0.381 | 0.332 | 0.339 | 0.329 | 0.713 | -0.164 | 0.003 |
| Operating Income
| -4.991 | -3.577 | -0.004 | -5.191 | -8.882 | -8.677 | -6.477 | -6.689 | -13.499 | -15.075 | -7.28 | -9.056 | -4.944 | -1.792 | -2.069 | -3.068 | -3.013 | -2.392 | -2.503 | -1.969 | -3.404 | -1.463 | -2.508 | -3.699 | -3.294 | -3.111 | -3.863 | -2.456 | -2.023 | -1.211 | -0.713 | -0.164 | -0.005 |
| Operating Income Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -2,508 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| 0.205 | -0.546 | 0.001 | 0.577 | -1.54 | -0.59 | -2.16 | -0.1 | -0.055 | -0.077 | -0.634 | -0.085 | -0.438 | -0.015 | 0.357 | 0.011 | 0.015 | -0.092 | -0.585 | -0.016 | 0.001 | -0.036 | 0.033 | 0.063 | 0.009 | -0.198 | 4.4 | -2.18 | -0.162 | -0.289 | -0.005 | 0 | 0 |
| Income Before Tax
| -4.786 | -4.123 | -0.003 | -4.614 | -10.422 | -9.267 | -8.637 | -6.789 | -13.554 | -15.152 | -7.914 | -9.141 | -5.382 | -1.807 | -1.712 | -3.057 | -2.998 | -2.484 | -3.088 | -1.985 | -3.403 | -1.499 | -2.475 | -3.636 | -3.285 | -3.309 | -4.161 | -2.512 | -2.185 | -1.5 | -0.718 | -0.164 | -0.005 |
| Income Before Tax Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -2,475 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| 0 | -0.546 | 0.005 | -0.005 | -0.009 | -0.009 | -5.677 | -0 | -0 | -0.003 | -3.18 | -0.054 | 0 | 0 | -1.543 | 0.011 | 0 | 0 | -1.687 | 0 | 0 | 0 | -2.406 | 0 | 0 | 0 | 2.918 | -2.124 | 0 | 0 | 0 | -0.164 | -0.005 |
| Net Income
| -4.786 | -4.123 | 0.001 | -4.614 | -10.422 | -9.267 | -2.96 | -6.789 | -13.554 | -15.152 | -4.734 | -9.141 | -5.382 | -1.807 | -0.169 | -3.057 | -2.998 | -2.484 | -1.401 | -1.985 | -3.403 | -1.499 | -0.069 | -3.636 | -3.285 | -3.309 | -2.381 | -2.512 | -2.185 | -1.5 | -0.718 | -0.164 | -0.005 |
| Net Income Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -69 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS
| -0.085 | -0.079 | 0 | -0.081 | -0.18 | -0.16 | -0.071 | -0.13 | -0.3 | -0.31 | -0.12 | -0.24 | -0.15 | -0.065 | -0.006 | -0.12 | -0.12 | -0.098 | -0.053 | -0.08 | -0.14 | -0.2 | -0.004 | -0.19 | -0.18 | -0.45 | -0.21 | -0.27 | -0.23 | -0.2 | -0.064 | -0.026 | -0.001 |
| EPS Diluted
| -0.085 | -0.079 | 0 | -0.081 | -0.18 | -0.16 | -0.071 | -0.13 | -0.29 | -0.31 | -0.11 | -0.24 | -0.15 | -0.063 | -0.006 | -0.1 | -0.12 | -0.098 | -0.053 | -0.076 | -0.14 | -0.2 | -0.004 | -0.14 | -0.17 | -0.35 | -0.21 | -0.27 | -0.23 | -0.16 | -0.064 | -0.026 | -0.001 |
| EBITDA
| -4.991 | -3.577 | 0.011 | -5.191 | -8.882 | -8.677 | -6.477 | -6.689 | -13.499 | -15.075 | -7.28 | -9.056 | -4.939 | -1.786 | -2.063 | -3.048 | -3.011 | -2.383 | -2.482 | -1.947 | -3.382 | -1.441 | -2.486 | -3.677 | -3.272 | -3.089 | -3.841 | -2.434 | -2.001 | -1.193 | -0.707 | -0.164 | -0.005 |
| EBITDA Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -2,486 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |